SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention as investors position for potential SpaceX and Anthropic liquidity events, with many viewing the fund as a concentrated proxy for these high-growth private tech assets. Market participants are actively comparing its valuation and portfolio density against other vehicles like VCX, debating whether the current price offers a strategic entry point relative to the fund's underlying net asset value.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened volatility and intense community debate as investors navigate a complex landscape of legal challenges, including trademark disputes with the NCAA and regulatory uncertainty surrounding the rise of prediction markets. While some investors view the recent price drop as a strategic buying opportunity driven by sentiment rather than fundamentals, others are aggressively shorting the stock, citing concerns over insider selling and a shifting competitive environment.

BioLLM

BioLLM is currently circulating across social platforms through aggressive promotional campaigns that frequently associate the token with major tech and financial assets. While some market participants are actively pushing for rapid price appreciation, others are voicing skepticism and labeling the asset as a speculative pump-and-dump scheme.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as investors digest a series of mixed financial performance signals and technical challenges that have frustrated the retail trading community. While the firm reports record client asset growth and robust engagement, users are actively venting about platform instability, restrictive trading policies on volatile stocks, and the ongoing integration pains following the TD Ameritrade acquisition.

Polywhale

The community is rallying behind KRILL as it gains traction on social media, with traders speculating on a potential rally fueled by a resurgence in the so-called ocean-themed token meta. Investors are drawing comparisons to previous sector movements while actively debating the token's growth potential and ecosystem connectivity.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a focal point for investors, driven by community enthusiasm for staking opportunities and its evolving role in institutional finance as a digital commodity. While some traders monitor price consolidation and market volatility, others remain bullish on its long-term utility, actively discussing accumulation strategies amidst broader macroeconomic uncertainty.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing extreme volatility and intense community speculation, driven by its high-purity exposure to high-profile private tech unicorns like SpaceX and Anthropic. Investors are actively debating whether the stock's massive premium over its net asset value represents a sustainable meme-driven breakout or an inevitable collapse as traders monitor limited share float and lock-up restrictions.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is facing a sharp sell-off despite delivering a double beat on earnings and revenue, as investors react negatively to licensing revenue falling short of high expectations and a broader market trend of rotating out of premium-priced tech. While community sentiment remains split between long-term believers in the company's AI-driven royalty growth and bears criticizing the high valuation multiples, the stock is experiencing significant volatility as it reconciles its strong guidance with a skeptical market backdrop.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as the market focuses on its role in the RWA narrative, with strong community interest driven by institutional partnerships with industry leaders like BlackRock. Despite persistent volatility and concerns regarding token unlock schedules, many investors remain bullish on the project's long-term potential as a bridge between traditional finance and blockchain infrastructure.

ORCASM is a filthy little memecoin that knows exactly what you came for. It launched on Orca's Wavebreak but was born to make waves—wet, loud, and unforgettable. This isn’t your ordinary meme. ORCASM builds up the tension slow, goes deep, and leaves you gasping for more. It’s raw, unfiltered trencher energy dripping with shameless satisfaction. No promises. No roadmaps. Just pure, orcasmic pleasure.

Orcasm

The ORCASM cryptocurrency is gaining significant momentum on social media as investors treat it as the latest high-risk, high-reward meme play following in the footsteps of similar marine-themed tokens. The community is actively debating the coin's potential to drop zeros and hit higher valuations while navigating intense skepticism and accusations of it being a pump-and-dump scheme.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ADC Therapeutics (NYSE:ADCT) Shares Gap Up on Analyst Upgrade

ADC Therapeutics (NYSE:ADCT) Shares Gap Up Following Analyst Upgrade...

ADC Therapeutics (NYSE:ADCT) Price Target Raised to $8.00

HC Wainwright boosted their target price on shares of ADC Therapeutics from $7.00 to $8.00 and gave the stock a "buy" rating in a research report on Monday...

Heights Capital Management Inc. Has $1.31 Million Position in ADC Therapeutics SA $ADCT

Heights Capital Management Inc. lessened its holdings in ADC Therapeutics SA (NYSE:ADCT - Free Report) by 88.5% during the third quarter, according to the company in its most recent filing with the...

Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?

Here is how ADC Therapeutics SA (ADCT) and ALX Oncology Holdings Inc. (ALXO) have performed compared to their sector so far this year.

ADC Therapeutics (NYSE:ADCT) Shares Down 9.2% - Should You Sell?

ADC Therapeutics (NYSE:ADCT) Trading Down 9.2% - Here's Why...

ADC Therapeutics (NYSE:ADCT) Reaches New 12-Month High Following Strong Earnings

ADC Therapeutics (NYSE:ADCT) Hits New 1-Year High After Strong Earnings...

ADC Therapeutics Q4 Earnings Call Highlights

ADC Therapeutics (NYSE:ADCT) outlined a 2025 strategy centered on expanding ZYNLONTA while significantly reducing costs, and management pointed investors to multiple clinical and regulatory catalysts...

ADC Therapeutics (NYSE:ADCT) Shares Gap Up After Strong Earnings

ADC Therapeutics (NYSE:ADCT) Shares Gap Up on Strong Earnings...

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +87.50% and +20.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

ADC Therapeutics Posts Narrower Loss In Q4

(RTTNews) - ADC Therapeutics SA (ADCT) reported a net loss for the quarter ended December 31, 2025, of $6.4 million, or a net loss of $0.04 per share, as compared to net loss of $30.7 million, or a...

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.20	--	--	N/A
Q4 '25	-$0.27	-$0.04	85.09%	BEAT
Q3 '25	-$0.36	-$0.30	17.43%	BEAT
Q2 '25	-$0.49	-$0.50	-1.63%	MISSED
Q1 '25	-$0.40	-$0.36	10.74%	BEAT

ADCT
Adc Therapeutics SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest ADCT News

ADCTAdc Therapeutics SA